INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE SUPPRESS LIPOPOLYSACCHARIDE-INDUCED NITRITE FORMATION IN MACROPHAGES

被引:38
|
作者
HAUSCHILDT, S
SCHEIPERS, P
BESSLER, WG
机构
[1] Institute of Immunobiology, University of Freiburg
关键词
D O I
10.1016/0006-291X(91)91898-M
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stimulating bone marrow derived macrophages with LPS results in the induction of NO-synthase as measured by NO2- formation. Inhibitors of poly(ADP-ribose)polymerase, namely nicotinamide, 3-aminobenzamide and 3-methoxybenzamide, prevented NO2- formation in a dose dependent manner. Inhibition was most effective if the inhibitors were added at the same time as LPS. When added 10h after exposure to LPS, a time at which expression of the enzyme had reached its maximum, no inhibition was observed. The inhibitors also blocked early events in activation such as protein and RNA-synthesis as well as DNA-synthesis. Thus prevention of NO2- formation may be related to inhibition of these events. Activation of macrophages by LPS was not accompanied by an increase but rather by a small decrease in ADP-ribosyltransferase activity. Whether this decrease plays a physiological role in activation needs further exploration. © 1991.
引用
收藏
页码:865 / 871
页数:7
相关论文
共 50 条
  • [1] Poly(ADP-Ribose) Polymerase Inhibitors
    Garon, Edward B.
    Dubnett, Steven M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S455 - S456
  • [2] Poly(ADP-ribose) polymerase inhibitors
    Southan, GJ
    Szabó, C
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (04) : 321 - 340
  • [3] Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?
    Vanacker, Helene
    Romeo, Clemence
    Ray-Coquard, Isabelle
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (05) : 394 - 403
  • [4] The clinical development of inhibitors of poly(ADP-ribose) polymerase
    Calvert, H.
    Azzariti, A.
    ANNALS OF ONCOLOGY, 2011, 22 : i53 - i59
  • [5] Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase
    Menear, Keith A.
    Adcock, Claire
    Alonso, Francisco Cuenca
    Blackburn, Kristel
    Copsey, Louise
    Drzewiecki, Jan
    Fundo, Alexandra
    Le Gall, Armelle
    Gomez, Sylvie
    Javaid, Hashim
    Lence, Carlos Fenandez
    Martin, Niall M. B.
    Mydlowski, Chris
    Smith, Graeme C. M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3942 - 3945
  • [6] Poly(ADP-ribose) polymerase inhibitors as cancer therapy
    Hilton, John F.
    Hadfield, Matthew J.
    Tran, Minh-Thu
    Shapiro, Geoffrey I.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1393 - 1407
  • [7] Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma
    Vormoor, Britta
    Curtin, Nicola J.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) : 428 - 433
  • [8] STRUCTURAL REQUIREMENTS FOR INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE
    SESTILI, P
    SPADONI, G
    BALSAMINI, C
    SCOVASSI, I
    CATTABENI, F
    DURANTI, E
    CANTONI, O
    HIGGINS, D
    THOMSON, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) : 615 - 622
  • [10] Poly (ADP-ribose) polymerase inhibitors in cancer therapy
    Zhu, Ziqi
    Shi, Yujun
    CHINESE MEDICAL JOURNAL, 2025, 138 (06) : 634 - 650